Il Messaggiere - Semenya set to end 5-year world championship absence in Eugene

NYSE - LSE
VOD -2.37% 15.58 $
RBGPF 0% 75.17 $
GSK -0.16% 50.33 $
BTI -3.6% 60.89 $
RIO 0.68% 83.73 $
BP -0.38% 44.53 $
CMSC -0.35% 20.05 $
RYCEF 0.3% 16.43 $
NGG -3.33% 83.15 $
AZN -0.23% 186.43 $
RELX -3.19% 40.17 $
BCC -5% 70.24 $
BCE -1.9% 21.62 $
JRI 1.81% 11.63 $
CMSD -0.1% 20.15 $
Semenya set to end 5-year world championship absence in Eugene
Semenya set to end 5-year world championship absence in Eugene / Photo: Fabien Dubessay - AFP

Semenya set to end 5-year world championship absence in Eugene

South Africa's double Olympic 800 metres champion Caster Semenya looks set to make her first appearance at a World Championships in five years in the 5,000 metres after being named in the list of registered athletes by World Athletics on Saturday.

Text size:

Semenya initially missed qualification when she only finished sixth at the African Championships last month but has benefitted from a number of athletes dropping out.

The World Championships run from July 15-24 in Eugene, Oregon.

The 31-year-old last competed at a world championships in London in 2017 where she won her third 800m world crown.

A year later she won double gold in the 800m and 1500m at the Commonwealth Games which is the last time she represented South Africa in a global international competition.

Semenya was forced to switch from her favoured distance to the longer event due to gender eligibility rules that required her to take testosterone-reducing drugs to compete in races between 400m to a mile.

World Athletics bar women athletes with high testosterone levels from competing in shorter races because the governing body says the hormone increases muscle mass and oxygen uptake.

Semenya, who became a world champion at 18 years of age in Berlin in 2009, has made several unsuccessful legal attempts to overturn the ruling.

In a bid to compete at the Tokyo Olympics, she even dropped down to the 200m, but was unsuccessful in her attempts to qualify.

V.Agnellini--IM